As neurofibrillary tangle pathology is the primary driver of neurodegeneration and cognitive decline in the AD continuum, it is not surprising that p-tau levels (likely related to NFT burden) would be predictive of decline in those with likely AD pathology (Aβ+). Here, MAPT is linked to Alzheimer disease.